Novo Integrated Sciences, Inc. · OTC:NVOS
Novo Integrated Sciences — Investor Presentation (September 2021)
25 slides from Novo Integrated Sciences's investor presentation, Sep 30, 2021
Slide 1: Novo Integrated Sciences, Inc. Investor Presentation
NOVO INTEGRATED SCIENCES, INC. NASDAQ: NVOS Investor Presentation September 30, 2021
Slide 2: Disclaimer
DISCLAIMER Disclaimers and Cautionary Statements: The information contained in this presentation is provided by Novo Integrated Sciences, Inc. (“Novo Integrated Sciences”) for informational purposes only and does not constitute an offer to sell, or the solicitation of an offer to purchase NVOS secur
Slide 3: Company Overview
COMPANY OVERVIEW Novo Integrated Sciences (NASDAQ: NVOS) is pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of services and product innovation. Decentralization allows for high quality, convenient, cost-effective non-critical healt
Slide 4: Lack of Innovation Facing the Healthcare Industry Globally
LACK OF INNOVATION FACING THE HEALTHCARE INDUSTRY GLOBALLY Healthcare globally today has not adopted the innovative pace of other industries, particularly during the pandemic. A key driver of innovation is technology, not as it relates to existing infrastructure and sophisticated practitioner techno
Slide 5: Vertically-Integrated Healthcare Ecosystem
VERTICALLY-INTEGRATED HEALTHCARE ECOSYSTEM Organically and through M&A + JV’s, NVOS has assembled a growing patient offering of products and services that all drive patient data to the center with vertical diagnostic capabilities through Al and securitization. Essential and differentiated solution t
Slide 6: Products & Services
& Primary Healthcare* Intellectual Property Interconnected Technology Medicinal Agriculture? Health & Wellness Products 1. Currently, Novo Integrated Sciences does not provide primary care medical services, none of our NASDAQ: NVOS loyees or PRODUCTS & SERVICES All products and services offered driv
Slide 7: Pillar 1: Hands on Patient Care
PILLAR 1: HANDS ON PATIENT CARE Building a foundation of traditional hands-on healthcare delivery, through small and micro footprint sized clinic facilities, within a significant service delivery network. > 16 corporate-owned clinics and a contracted network of affiliate clinics and eldercare centri
Slide 8: Primary: LA Fitness Partnership Micro Clinics
lu ce <x O ag 5 <x wi ac PRIMARY LA FITNESS PARTNERSHIP Micro Clinics —"—— LAIFITNESS. i NASDAQ: NVOS > Master Facility License Agreements with LA Fitness U.S. and Canada to locate micro-clinics inside U.S. and Canada based LA Fitness facilities During Phase 1 roll-out, NVOS will provide limited mul
Slide 9: Entrance into U.S.
ENTRANCE INTO U.S. LOI’s to Acquire 7 Pharmacies Signed non-binding Letters of Intent (“LOI’s”) to acquire 7 pharmacies in the U.S. with locations in Florida, Virginia and Arizona. > Vv Vv Vv > Collectively, the pharmacies generated approximately $55 million in annualized sales in 2020 We believe da
Slide 10: Pillar 2: Interconnected Technology
. ) S NASDAQ: NVOS PILLAR 2: INTERCONNECTED TECHNOLOGY Making a Global Impact on Health Development, integration, and deployment of sophisticated technology, through interconnectivity led by NovoConnect, a NVOS proprietary mobile application > In doing so, NVOS is expanding the reach of healthcare r
Slide 11: Technology: NovoConnect
TECHNOLOGY (a) Ld = oO Lud 2 2 je} oO a Lud = = NOVOCONNECT NovoConnect, a NVOS proprietary secure mobile application, finally puts the patient-first through a robust healthcare ecosystem of services, products and digital health offerings alongside a secure patient chart that empowers the patient to
Slide 12: NovoConnect Capabilities
NOVOCONNECT CAPABILITIES ¢ Intended to provide a suite of secure, reliable engagement features, such as: Appointment scheduling Bi-directional interface with Electronic Health Records (EHR) Access to Forms and Documents Distribute patient data from C-CDAs to the patient portal regardless of source E
Slide 13: Telemedicine
> © ie} —_ fe) 2 ai oO Lud = (a) Ld = oO wi 2 2 je} oO a Lud — = TELEMEDICINE > Joint Venture with EK-Tech Solutions (MiTeleMed+) > Operational platform which utilizes proprietary source code for Enhanced Telehealth > Peripheral based tools allow for uniquely comprehensive practitioner evaluation an
Slide 14: Technology: Remote Patient Monitoring
TECHNOLOGY (a) Ld = oO Lud 2 2 je} oO a Lud = = NVOS and Cloud DX are parties to an exclusive Licensing Agreement specific to physical therapy, wellness, REMOTE PATIENT MONITORING and para-medical services in the U.S. and Canada. i NASDAQ: NVOS > Vv The Cloud DX technology empowers a patient with re
Slide 15: Pillar 3: Health & Wellness Products
2) E Oo = a) 2) a a a) Me) Lad 2 a — Mut S ,) ae 5 — tid <= PILLAR 3: HEALTH & WELLNESS PRODUCTS R&D, Manufacturing and Distribution Development and distribution of effective wellness product solutions allowing for the customization of patient preventative care remedies and ultimately a healthier po
Slide 16: PRO-DIP
PRO-DIP NVOS acquired 100% ownership of PRO-DIP on May 24, 2021 in an all-share transaction. Vv Vv Proprietary, patent-pending oral pouch technology for consumers and enterprise. > Energy Pouch commercialized today. Additional 6 pouch types to be commercialized beginning early 2022 such as_ hydratio
Slide 17: Acenzia
7) =) a) Oo ~ a wn %) Lu 2 =_l = rr S ,) ae ar < ui as © acenzia” Provides nutraceutical health solutions through advanced bio-science research and development, proprietary manufacturing, and personalized diagnostics: \) NVOS acquired 100% ownership of Acenzia on June 24, 2021 in an all-share transa
Slide 18: Medicinal Agriculture
MEDICINAL AGRICULTURE > MEDICINAL AGRICULTURE JOINT VENTURES Kainai Cooperative Novo Earth Therapeutics Kainai Cooperative 50-year term for rights to 275,000 acres of prairie land in Alberta Canada Direct control of grow, cultivation, extraction, and manufacturing process for hemp and medicinal cann
Slide 19: Intellectual Property
INTELLECTUAL PROPERTY Zgraft - Tru-Dose +» Generic Formulas Zgraft Tru-Dose Vaporizer > Patented platform that transplants human > Specific for medical cannabis applications cancer cells into zebrafish which have a long > Analyzes the amount of THC/CBD in the smoke/vapor history of various modeling
Slide 20: Senior Management Team
SENIOR MANAGEMENT TEAM Insider’s currently own 68.8% of the issued and outstanding common stock Robert Mattacchione, Board Chairman & CEO, Novo Integrated Sciences and Chairman, Novo Healthnet Limited Mr. Mattacchione brings knowledge and experience leading the development of operational business in
Slide 21: Board of Directors
BOARD OF DIRECTORS Dr. Pierre Dalcourt, D.C. - Director Dr. Dalcourt’s 26 years of experience as a chiropractic business owner provides the company with a deep knowledge base related to patient treatment, rehabilitation and wellness protocols combined with scalable business development. Dr. Dalcourt
Slide 22: Medical Advisory Board
ay cA MEDICAL ADVISORY BOARD Dr. Joseph M. Chalil, MD, MBA, FACHE; Chairman NVOS Medical Advisory Board Dr. Chalil is distinguished as an expert in U.S. healthcare policy and a strong advocate for patient-centered care. A strong proponent of providing healthcare access for everyone, Dr. Chalil's new
Slide 23: Select Financial Information
SELECT FINANCIAL INFORMATION Capitalization Structure For the Fiscal 3° quarter Period (ended 5/31/21) Current Share Price (9/21/21): $1.92 Cash and Cash Equivalents: $8.367M ($0.31/share) Shares Outstanding (7/14/21): 26,645,144 Revenue (9-months ended 5/31/21): $6.6M (+10% YOY) Market Capitalizati
Slide 24: Investment Highlights
INVESTMENT HIGHLIGHTS 7 Oar fa Multifaceted Healthcare Service Provider? ~ Provider of a full suite of primary healthcare services to company owned and affiliated clinics, eldercare ,, and micro clinic partnership facilities ( > c= Sas Qa Expansion into Tele-Health Completed exclusive licensing agre
Slide 25: Contact Us
CONTACT US Canada Headquarters Robert Mattacchione, CEO 3905 Major MacKenzie Dr., Suite 115 Vaughan Ontario Canada L4H 4J9 Phone: (647) 829-7997 Email: robert.mattacchione@novointegrated.com NOVO INTEGRATED SCIENCES, INC. USA Headquarters Chris David, COO/President NAS DAQ: NVOS 11120 NE 2nd Street,
Novo Integrated Sciences — Investor Presentation (September 2021) on 6ix